2m 2m 2m 2m 2m 2m 2m
SOTERA HEALTH (SHC)
NASDAQ
$15.90+$0.33 (+2.12%)
Price as of Jun 05, 2026 8:46 AM EDT- $4.5BMarket Cap
- 27.73%1-Year Change
- Diagnostics & ResearchIndustry
SOTERA HEALTH (SHC)
$15.90+$0.33 (+2.12%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 995.8M -9.51% | 1.1B +4.88% | 1.0B +4.54% | 1.0B +7.75% | |
Cost of Revenue | 456.3M -8.40% | 498.1M +5.51% | 472.1M +5.70% | 446.7M +8.21% | |
Gross Profit | 645.5M +7.18% | 602.3M +4.36% | 577.2M +3.62% | 557.0M +7.39% | |
Sales and Marketing Expense | 252.8M +4.18% | 242.6M +2.52% | 236.7M -3.68% | 245.7M +24.00% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 41.8M -47.34% | 79.4M -2.42% | 81.3M -0.25% | 81.6M -5.98% | |
Total Operating Expenses | 252.8M -17.04% | 304.7M +1.40% | 300.5M -2.65% | 308.7M +17.83% | |
Operating Profit | 147.5M -50.44% | 297.6M +7.57% | 276.7M +11.41% | 248.3M -3.27% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -155.7M -5.45% | -164.7M +15.27% | -142.9M +78.28% | -80.1M +8.02% | |
Interest Income and Expense and Net | -155.7M -5.45% | -164.7M +15.27% | -142.9M +78.28% | -80.1M +8.02% | |
Total Nonoperating Income and Expense | 8.5M +61.06% | 5.3M -28.02% | 7.4M +14.45% | 6.4M -57.63% | |
Income before Taxes | 147.5M +29.53% | 113.9M +7.40% | 106.0M +143.61% | -243.1M -238.35% | |
Income Taxes | 69.6M +0.12% | 69.5M +27.13% | 54.7M +672.80% | -9.5M -116.28% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 77.9M +75.57% | 44.4M -13.58% | 51.4M +122.00% | -233.6M -299.83% | |
Net Income from Continuing Operations Applicable to Common | 147.5M +29.53% | 113.9M +7.40% | 106.0M +143.61% | -243.1M -238.35% | |
Basic EPS and Net Income | 0.27 +68.75% | 0.16 -11.11% | 0.18 +121.69% | -0.83 -302.44% | |
Diluted EPS and Net Income | 0.27 +68.75% | 0.16 -11.11% | 0.18 +121.69% | -0.83 -302.44% | |
Basic Weighted Average Shares | 284.0M +0.41% | 282.8M +0.63% | 281.0M +0.33% | 280.1M +0.31% | |
Diluted Weighted Average Shares | 286.4M +0.53% | 284.9M +0.59% | 283.2M +1.12% | 280.1M +0.26% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 344.6M +24.30% | 277.2M -6.47% | 296.4M -25.00% | 395.2M +269.65% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 344.6M +24.30% | 277.2M -6.47% | 296.4M -25.00% | 395.2M +269.65% | |
Total Current Assets | 613.4M +16.61% | 526.0M -5.60% | 557.2M -13.61% | 645.0M +86.44% | |
Accumulated Depreciation | 671.9M +19.46% | 562.4M +11.42% | 504.8M +15.01% | 438.9M +12.42% | |
Property and Plant and Equipment and Net | 1.1B +9.03% | 1.0B +9.50% | 946.9M +22.26% | 774.5M +19.01% | |
Total Long-Term Assets | 36.7M -0.97% | 37.1M -10.16% | 41.2M +5.79% | 39.0M +202.99% | |
Total Assets | 3.3B +6.24% | 3.1B -1.88% | 3.1B +0.41% | 3.1B +11.77% | |
Income Taxes Payable | 76.8M -0.38% | 77.1M +12.32% | 68.6M -7.16% | 73.9M -47.67% | |
Total Short-Term Debt | 14.0M -5.61% | 14.8M +208.59% | 4.8M -97.57% | 197.1M N/A | |
Total Current Liabilities | 249.6M +30.67% | 191.0M -17.19% | 230.7M -70.86% | 791.6M +391.17% | |
Total Long-Term Debt | 2.1B -3.69% | 2.2B -0.70% | 2.2B +27.28% | 1.7B +0.21% | |
Total Long-Term Liabilities | 7.4M +66.59% | 4.4M -50.24% | 8.9M -30.80% | 12.8M -21.16% | |
Total Liabilities | 2.7B -0.36% | 2.7B -0.74% | 2.7B -2.92% | 2.8B +25.60% | |
Retained Earnings | -532.1M -12.78% | -610.0M -6.78% | -654.4M -7.28% | -705.8M +49.46% | |
Total Stockholders Equity | 606.0M +49.67% | 404.9M -8.75% | 443.7M +26.69% | 350.2M -40.24% | |
Total Shares Outstanding | 286.0M 0.00% | 286.0M 0.00% | 286.0M 0.00% | 286.0M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 287.2M +28.12% | 224.2M +251.74% | -147.7M -153.15% | 278.0M -1.27% | |
Capital Expenditures | 138.0M -22.93% | 179.1M -16.70% | 215.0M +17.87% | 182.4M +78.52% | |
Cash from Investing Activities | -135.1M -24.50% | -179.0M -16.71% | -214.9M +18.15% | -181.9M +13.80% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -100.5M +98.83% | -50.6M -119.01% | 266.0M +34.49% | 197.8M +268.61% | |
Financials Ratio | |||||
Gross Margin | 54.17% -1.02% | 54.73% -0.50% | 55.00% -0.88% | 55.50% N/A | |
Operating Margin | 14.81% -45.23% | 27.05% +2.57% | 26.37% +6.57% | 24.74% N/A | |
Return on Assets | 2.46% +71.89% | 1.43% -12.94% | 1.64% +120.80% | -7.91% N/A | |
Return on Equity | 15.42% +47.38% | 10.46% -19.15% | 12.94% +125.94% | -49.89% N/A | |
Revenue Growth | -9.51% -295.14% | 4.88% +7.30% | 4.54% -41.39% | 7.75% N/A | |
Current Ratio | 2.46 -10.76% | 2.75 +14.00% | 2.42 +196.47% | 0.81 N/A | |
Cash Ratio | 1.38 -4.87% | 1.45 +12.95% | 1.29 +157.38% | 0.50 N/A | |
Debt-to-Equity Ratio | 3.53 -35.66% | 5.49 +9.31% | 5.02 -9.53% | 5.55 N/A | |
Debt-to-Assets Ratio | 0.66 -9.35% | 0.72 +1.66% | 0.71 +14.16% | 0.62 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow